M3 Wake Research, an integrated network of clinical research sites and provider of Phase I-IV clinical trials, expanded operations into Charleston, SC, with the opening of a clinical research practice. Operating as Charleston Clinical Trials, LLC, the new center will be led by Donald Hurley.

The Charleston team will provide clinical research services in a variety of therapeutic areas including vaccines, gastroenterology, cardiovascular disease hypertension, diabetes, and urology.

Hurley, who will serve as principal investigator, brings more than 35 years of clinical experience to Charleston Clinical Trials, including 18 years in clinical research as a principal and sub-investigator in more than 40 therapeutic areas, with Medical Research South, LLC.

“I am excited to join the M3 Wake Research network and anticipate the continued growth of our Phase 2-4 trial base here in Charleston,” said Hurley. “This is a diverse, active market in a growing area, and we look forward to providing access to more investigative therapies to the community here.”

Hurley is supported by an experienced clinical research team including a certified clinical research coordinator who is managing the site operations of Charleston Clinical Trials.